The FDA authorized COVID booster doses of the Pfizer-BioNTech vaccine for people 65 and older and those whose jobs put them at high risk for exposure.
USA TODAY, The News Journal
Wed, 09/22/2021 - 5:33pm
The FDA authorized COVID booster doses of the Pfizer-BioNTech vaccine for people 65 and older and those whose jobs put them at high risk for exposure.